OPPORTUNITIES TO IMPROVE LIFE QUALITY OF PATIENTS WITH ACUTE CORONARY SYNDROME
https://doi.org/10.29001/2073-8552-2015-30-4-19-23
Abstract
The pilot randomized prospective comparative study comprised 54 patients with acute coronary syndrome (ACS) with anxiety and depressive disorders. Patients were admitted to the Emergency Department of the Federal State Budgetary Scientific Institution “Research Institute for Cardiology”. Patients were tested for mental status, sleep quality, and quality of life at discharge and after at 6-month follow-up. During conventional therapy of ACS, patients of group 1 (n=27) were administered with Tenoten; patients of group 2 (n=27) were administered with placebo (groups were randomized). Patients had increased level of anxiety and depression at admission. At 6-month follow up, mental status, sleep quality, and quality of life improved in Tenoten group. In placebo group, mental status of patients and sleep quality did not change. The results showed positive effects of Tenoten therapy on mental status, sleep quality, and quality of life.
About the Authors
T. M. Poponina
Siberian State Medical University
Russian Federation
Russian Federation
K. I. Gunderina
Siberian State Medical University; Federal State Budgetary Scientific Institution “Research Institute for Cardiology”
Russian Federation
Russian Federation
Y. S. Poponina
Siberian State Medical University; Federal State Budgetary Scientific Institution “Research Institute for Cardiology”
Russian Federation
Russian Federation
M. V. Soldatenko
Federal State Budgetary Scientific Institution “Research Institute for Cardiology”
Russian Federation
Russian Federation
V. A. Markov
Siberian State Medical University; Federal State Budgetary Scientific Institution “Research Institute for Cardiology”
Russian Federation
Russian Federation
References
1. Боровков Н., Бердникова Л., Добротина И. О лечении тревожно-депрессивных расстройств у пациентов сердечно-сосудистыми заболеваниями // Врач. - 2013. - № 12. - С. 1-5.
2. ВОЗ. Информационный бюллетень № 310 “10 ведущих причин смерти в мире”, май 2014 г. [Электронный ресурс]. - URL: http://www.who.int/mediacentre/factsheets/fs310/ru/index4.html (дата обращения 23.09.2015).
3. Иванов С.В. Тревожные расстройства в общей медицине (клиника, фармакотерапия) // Психиатрия и психофармакотерапия. - 2013. - № 4. - С. 15-19.
4. Корнетов Н.А., Лебедева Е.В. Депрессивные расстройства у пациентов, перенесших инфаркт миокарда // Психиатрия и психофармакотерапия. - 2003. - № 5. - С. 195-198.
5. Попонина Т.М., Гундерина К.И., Попонина Ю.С., Марков В.А. Оценка психического статуса и его коррекция Вальдоксаном у больных с острым коронарным синдромом // Бюллетень сибирской медицины. - 2013. - Т. 12, № 6. - С. 48-53.
6. Репин А.Н., Лебедева Е.В., Сергиенко Т.Н., Счастный Е.Д., Симуткин Г.Г. Клиническое течение заболевания у пациентов с ИБС в сочетании с тревожно-депрессивными расстройствами на фоне длительной терапии антидепрессантами // Сибирский медицинский журнал (Томск) - 2010. - Т. 25, № 2. - С. 20-25.
7. Annagьr B.B., Avci A., Demir K., Uygur O.F. Is there any difference between the early age myocardial infarction and late age myocardial infarction in terms of psychiatric morbidity in patients who have survived acute myocardial infarction? // Comprehensive Psychiatry. - 2015. - Vol. 57. - P. 10-15.
8. Bush D.E., Ziegelstein R.C., Tayback M. et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction // Am. J. Cardiol. - 2001. - Vol. 88. - Р. 337-341.
Review
For citations:
Poponina T.M., Gunderina K.I., Poponina Y.S., Soldatenko M.V., Markov V.A. OPPORTUNITIES TO IMPROVE LIFE QUALITY OF PATIENTS WITH ACUTE CORONARY SYNDROME. Siberian Journal of Clinical and Experimental Medicine. 2015;30(4):19-23. (In Russ.) https://doi.org/10.29001/2073-8552-2015-30-4-19-23
Views:
332
.png)
Email this article 